BioLineRx Ltd. (BLRX) stock Popping High in Pre-Market: Why is it so?
BioLineRx Ltd. (BLRX) announced positive topline results of its GENESIS Phase 3 trial after which the BLRX stock price saw a surge of 65.52% to reach $5.28 a share as of this writing. BLRX stock went up by 1.59% at the previous closing. Let’s deep dive to explore more of it. GENESIS Phase 3 Trial: […]